The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare eye condition known as NAION (non-arteritic anterior ischemic optic ...
MedPage Today on MSN
GLP-1 drug linked to cases of rare vision-altering condition
Resolution occurred after stopping dulaglutide, no obvious clues to mechanism ...
GLP-1 receptor agonist medications like Ozempic have been talked about so much that you its side effects (like nausea and diarrhea) are practically common knowledge. But while many people expect some ...
Morning Overview on MSN
Early data ties Wegovy to rare eye stroke risk, researchers say
When a study published in JAMA Ophthalmology reported that semaglutide users developed a rare form of sudden vision loss at ...
Authors of a new study say additional research is needed to determine causality between semaglutide and a condition called NAION Tommy McArdle is a Writer-Reporter on the Movies team at PEOPLE. He ...
Use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) may be linked with an increased risk of the second most common form of optic neuropathy, a retrospective study suggested. Over a mean ...
A new observational study on Wednesday reported for the first time a potential link between Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy and an eye condition that can cause vision loss. After hearing ...
GLP-1 receptor agonists (RA) may increase the risk of non-arteritic anterior ischemic optic neuropathy (NAION), although the absolute risk is low. Studies supporting the association have reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results